(Press-News.org) A nationwide consortium of scientists has reported the first comprehensive genetic analysis of squamous cell carcinoma of the lung, a common type of lung cancer responsible for about 400,000 deaths each year.
"We found that almost 75 percent of the patients' cancers have mutations that can be targeted with existing drugs -- drugs that are available commercially or for clinical trials," says one of the lead investigators, Ramaswamy Govindan, MD, an oncologist at Washington University School of Medicine in St. Louis and co-chair of the lung cancer group of The Cancer Genome Atlas.
The research appears online Sept. 9 in Nature.
The Cancer Genome Atlas project combines efforts of the nation's leading genetic sequencing centers, including The Genome Institute at Washington University, to describe the genetics of common tumors with the goal of improving prevention, detection and treatment. The Cancer Genome Atlas is supported by the National Cancer Institute and the National Human Genome Research Institute, both parts of the National Institutes of Health (NIH).
The other lung cancer co-chairs are the study's senior author Matthew Meyerson, MD, PhD, of the Broad Institute of Massachusetts Institute of Technology and Harvard University, and Stephen Baylin, MD, of Johns Hopkins University.
The study examined the tumors and normal tissue of 178 patients with lung squamous cell carcinoma. The investigators found recurring mutations common to many patients in 18 genes. And almost all of the tumors showed mutations in a gene called TP53, known for its role in repairing damaged DNA.
Interestingly, the researchers noted that lung squamous cell carcinoma shares many mutations with head and neck squamous cell carcinomas, supporting the emerging body of evidence that cancers may be more appropriately classified by their genetics rather than the primary organ they affect.
"We clearly see mutations in lung cancer that we see in other human cancers," says Richard K. Wilson, PhD, director of The Genome Institute at Washington University. "This reinforces something that we've been seeing in a lot of our cancer genomics work. It's really less about what type of tissue the tumor arises in – lung, breast, skin, prostate – and more about what genes and pathways are affected."
Current treatment for squamous cell lung cancers includes chemotherapy and radiation, but there are no drugs specifically designed to target this particular type of lung cancer. Squamous cell lung cancer is linked to smoking and responsible for 30 percent of all lung cancer cases.
"With this analysis, we are just starting to understand the molecular biology of lung squamous cell carcinoma," says Govindan, who treats patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University. "And now we have identified potential targets for therapies to study in future clinical trials."
###
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. Sept. 9, 2012
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Large lung cancer study shows potential for more targeted therapies
2012-09-10
ELSE PRESS RELEASES FROM THIS DATE:
Protecting genes, one molecule at a time
2012-09-10
An international team of scientists have shown at an unprecedented level of detail how cells prioritise the repair of genes containing potentially dangerous damage. The research, published in the journal Nature and involving academics from the University of Bristol, the Institut Jacques-Monod in France and Rockefeller University in the US, studied the action of individual molecules in order to understand how cellular repair pathways are triggered.
The genetic information that forms the "instruction booklet" for cells is encoded in the molecular building blocks of DNA, ...
Nano-velcro clasps heavy metal molecules in its grips
2012-09-10
Mercury, when dumped in lakes and rivers, accumulates in fish, and often ends up on our plates. A Swiss-American team of researchers led by Francesco Stellacci at the Ecole Polytechnique Fédérale de Lausanne (EPFL) and Bartosz Grzybowski at Northwestern University has devised a simple, inexpensive system based on nanoparticles, a kind of nano-velcro, to detect and trap this toxic pollutant as well as others. The particles are covered with tiny hairs that can grab onto toxic heavy metals such as mercury and cadmium. This technology makes it possible to easily and inexpensively ...
UNC Lineberger scientists lead definition of key lung cancer genome
2012-09-10
In the September 9, 2012 early online edition of Nature, scientists with The Cancer Genome Atlas (TCGA) report that they have characterized the lung squamous cell carcinoma genome.
Squamous cell carcinoma is the second most common form of lung cancer, a disease that kills more Americans than any other type of cancer.
The national team of scientists examined tumor samples from 178 patients with untreated lung squamous cell carcinoma and completed genetic analysis of the tumors, work that paves the way for developing better, more targeted therapies to treat the cancer. ...
New potential targets discovered for treating squamous cell lung cancers
2012-09-10
Cambridge and Boston, MA. Sunday, September 9, 2012 – A new paper published online in Nature holds out hope that people with the second most common type of lung cancer may one day benefit from targeted therapies that have transformed treatments for other lung cancer patients.
Squamous cell lung cancer kills more people each year than breast, colorectal, or prostate cancer, ranking second only to lung adenocarcinoma in the number of deaths it causes. But unlike the most common form of lung cancer, squamous cell carcinoma has no treatments aimed at the specific genetic ...
Research finds novel airborne germ-killing oral spray effective in fighting colds and flu
2012-09-10
University Hospitals Case Medical Center clinical researchers will present findings about a one-two punch to prevent colds and flu in San Francisco at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) on Sept. 9.
The research team is presenting data in two poster presentations that a new oral antiseptic spray is effective in killing 99.9 percent of infectious airborne germs. Findings from these two presentations led to the development of Halo Oral Antiseptic, a first-of-its kind germ-fighting spray which is currently on store shelves.
"Respiratory ...
Wolf mange part of nature's cycle
2012-09-10
Mange and viral diseases have a substantial, recurring impact on the health and size of reintroduced wolf packs living in Yellowstone National Park, according to ecologists.
Following the restoration of gray wolves to Yellowstone in 1996, researchers collected blood from the animals to monitor parasite-induced disease and death. They also tracked the wolves in each pack to follow their survival and allow additional data-gathering.
"Many invasive species flourish because they lack their native predators and pathogens, but in Yellowstone we restored a native predator ...
Forest mortality and climate change: The big picture
2012-09-10
Washington, D.C.— Over the past two decades, extensive forest death triggered by hot and dry climatic conditions has been documented on every continent except Antarctica. Forest mortality due to drought and heat stress is expected to increase due to climate change. Although research has focused on isolated incidents of forest mortality, little is known about the potential effects of widespread forest die-offs. A new analysis of the current literature on this topic by Carnegie's William and Leander Anderegg is published September 9 in Nature Climate Change.
Along with ...
Enough wind to power global energy demand
2012-09-10
Washington, D.C.— There is enough energy available in winds to meet all of the world's demand. Atmospheric turbines that convert steadier and faster high-altitude winds into energy could generate even more power than ground- and ocean-based units. New research from Carnegie's Ken Caldeira examines the limits of the amount of power that could be harvested from winds, as well as the effects high-altitude wind power could have on the climate as a whole. Their work is published September 9 by Nature Climate Change.
Led by Kate Marvel of Lawrence Livermore National Laboratory, ...
Marijuana use may increase risk of testicular cancer
2012-09-10
A new study from the University of Southern California (USC) has found a link between recreational marijuana use and an increased risk of developing subtypes of testicular cancer that tend to carry a somewhat worse prognosis. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that the potential cancer-causing effects of marijuana on testicular cells should be considered not only in personal decisions regarding recreational drug use, but also when marijuana and its derivatives are used for therapeutic purposes in ...
Continuing management needed for most threatened and endangered species
2012-09-10
The Endangered Species Act (ESA)—the key US law protecting species listed as threatened or endangered—focuses on boosting species' numbers until they reach recovery thresholds and so can be taken off the ESA list. Almost 1400 species are now listed. Yet as many as 84 percent of currently listed species with management plans will face threats to their biological recovery even after they are considered "recovered" under the act, according to an article by Dale D. Goble and his colleagues in the October issue of BioScience. These species will require continuing management ...